I am still concerned by the discourse around the Medical Device Directive, and its possible recast, which may draw it closer to pharmaceutical regulation. Medical devices are significantly different than pharmaceutical products and deserve their own regulations without the added complications of pharmaceutical laws which could hinder innovative development and penalise small businesses. Such a change could also highlight further the current inconsistencies between Notified Bodies which appears to be on the increase.